Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and focuses primarily on gastrointestinal (GI) disorders. Founded in 2001, Salix has established itself as a leader in developing innovative therapies that address unmet medical needs in the GI space. The company’s core products, including treatments for conditions such as irritable bowel syndrome and inflammatory bowel disease, are distinguished by their efficacy and patient-centric approach.
With a strong market position, Salix has achieved significant milestones, including the successful launch of several key medications that have transformed patient care. The company’s commitment to research and development, alongside its strategic partnerships, has solidified its reputation as a trusted provider of specialised GI therapies, making it a vital contributor to the healthcare landscape.
-11 vs industry average
Salix Pharmaceuticals, Inc.’s score of 27 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Salix Pharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
No industry performance data available yet.
The Pharmaceutical Preparation Manufacturing industry
Reported emissions
No reported emissions data is available for Salix Pharmaceuticals, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Salix Pharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Salix Pharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Bausch Health Companies Inc.
Carbon Disclosure Project
Inherited from Bausch Health Companies Inc.
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Salix Pharmaceuticals, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project